Annuobode
Latest round
- Series A
Last raised
- Apr 2018
Total raised
- Undisclosed
Investors
- 1
About Annuobode
Established in 2017 and based in Ningbo, China, Annuobode is a biopharmaceutical company that develops tumor immuno-antibody drugs and gene-based drugs. The company has applied for a number of registered patents covering CAR-T, PD1 multiple tumor immunotherapy areas. The core team members are from University of Oklahoma, Shanghai Institute of Biochemistry and Cellular Research of Chinese Academy of Sciences and other universities and research institutes, and are proficient in antibody engineering, immunology, virology and other disciplines. The company has about 1000m2 GMP standard cell preparation workshop, molecular biology laboratory in Malaysia, Israel and other countries also have CAR-T multi-center clinical trial translation base. The company mainly develops anti-cancer and gene drugs in the field of CAR-T cells, TCR-T and CAR-NK. It also has an antibody screening platform, a clinical lentivirus production platform and a cell gene editing platform.
Who invested in Annuobode
1 investor across 1 round
See all investors in Annuobode
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 19, 2018
Amount
Undisclosed
Investors
Questions about Annuobode
Who invested in Annuobode?
Annuobode has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Annuobode raised?
Annuobode has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Annuobode last raise money?
Annuobode's most recent round on record is a Series A, in Apr 2018.
What does Annuobode do?
Established in 2017 and based in Ningbo, China, Annuobode is a biopharmaceutical company that develops tumor immuno-antibody drugs and gene-based drugs.
Where is Annuobode headquartered?
Annuobode is headquartered in Ningbo, China.
Which VCs invest in companies like Annuobode?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Annuobode's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Annuobode? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.